Central nervous system neuroblastoma – Life with Disease

Go back

Central nervous system neuroblastoma is a rare childhood cancer that originates from developing nerve cells within the brain or spinal cord. Unlike typical neuroblastomas that form outside the central nervous system—most commonly in the adrenal glands—this variant grows directly in the brain or spinal tissues. It primarily affects young children and presents unique challenges in diagnosis, treatment, and long-term care, making understanding of this condition essential for families navigating their child’s journey.

Understanding the Outlook: What to Expect

When a child is diagnosed with central nervous system neuroblastoma, one of the most pressing questions families face is about the future. The prognosis for this rare cancer depends heavily on several factors, including the child’s age at diagnosis, the location of the tumor within the brain or spinal cord, and whether the cancer has spread to other parts of the body. Prognosis refers to the expected course and outcome of the disease—essentially, what the medical team anticipates will happen over time with or without treatment.[2]

Central nervous system neuroblastoma is classified as a malignant tumor, meaning it has the potential to grow aggressively and spread. The location within the central nervous system matters significantly. Tumors that can be completely removed surgically tend to have better outcomes than those in locations where complete removal would damage critical brain or spinal cord structures. When the tumor wraps around blood vessels or invades vital areas, treatment becomes more complex and outcomes may be less favorable.[14]

Age plays a crucial role in determining outcomes. While neuroblastomas outside the central nervous system often affect infants—who sometimes experience spontaneous tumor regression—central nervous system variants follow different patterns. Children diagnosed at different ages may respond differently to the same treatments. The biological characteristics of the tumor itself, including specific genetic features, also influence how aggressive the disease behaves and how well it responds to therapy.[15]

Statistical survival rates for central nervous system neuroblastoma are difficult to establish precisely because the condition is so rare, with only a few hundred cases described in medical literature worldwide. This rarity means that doctors often rely on experiences from similar pediatric brain tumors to guide treatment decisions. However, advances in understanding the tumor’s genetic makeup and new therapeutic approaches continue to improve possibilities for children facing this diagnosis.[2][14]

⚠️ Important
Every child’s situation is unique, and prognosis discussions with your healthcare team should focus on your specific child’s case. General statistics may not reflect individual circumstances, as factors like tumor location, genetic characteristics, and response to initial treatment all significantly influence outcomes. Regular communication with your medical team helps you understand your child’s particular journey.

How the Disease Progresses Without Treatment

Understanding how central nervous system neuroblastoma develops naturally—without medical intervention—helps families appreciate the importance of timely diagnosis and treatment. This cancer originates from immature nerve cells called neuroblasts, which are cells that should have matured into functioning nerve tissue during fetal development. When these cells fail to mature properly and instead begin growing uncontrollably, they form a tumor within the brain or spinal cord.[2]

Without treatment, the tumor continues to grow, gradually taking up more space within the skull or spinal canal. Because the skull is a fixed, rigid structure, there is limited room for expansion. As the tumor enlarges, it begins to press on surrounding brain tissue, interfering with normal brain function. This pressure can disrupt the flow of cerebrospinal fluid—the protective liquid that cushions the brain and spinal cord—leading to a buildup of fluid and increased pressure inside the skull.[14]

The location of the tumor determines which functions become affected first. A tumor in the frontal region might initially cause changes in behavior or personality, while one near motor control areas could lead to weakness or movement problems. Tumors in the spinal cord may cause numbness, weakness in the legs, or problems with bladder and bowel control. As the tumor continues growing, symptoms become more severe and additional areas of the brain or spinal cord become affected.[15]

Unlike some neuroblastomas that occur outside the central nervous system—which occasionally regress spontaneously in very young infants—central nervous system neuroblastomas typically do not disappear on their own. The natural progression is toward increasing size and worsening symptoms. The tumor may also seed cancer cells through the cerebrospinal fluid to other parts of the brain or spinal cord, a process called metastasis. This spreading can create multiple tumor sites, each contributing to the overall burden of disease.[14]

Potential Complications That May Arise

Children with central nervous system neuroblastoma face various complications that can develop either from the tumor itself or as consequences of treatment. Understanding these possibilities helps families prepare and recognize warning signs that require immediate medical attention.

One significant complication is increased intracranial pressure—a dangerous condition where pressure builds up inside the skull. As the tumor grows, it occupies space that should be filled with brain tissue and cerebrospinal fluid. The skull cannot expand to accommodate this extra mass, so pressure increases. Symptoms include severe headaches that worsen over time, persistent vomiting (especially in the morning), vision changes, and altered consciousness. If left unaddressed, severe intracranial pressure can lead to brain damage or life-threatening herniation, where brain tissue is pushed into spaces it shouldn’t occupy.[14]

Hydrocephalus is another complication where cerebrospinal fluid accumulates excessively within the brain’s ventricles (fluid-filled spaces). The tumor can block normal fluid pathways, preventing proper drainage. This backup of fluid further increases pressure and can cause the head to enlarge in infants whose skull bones haven’t yet fused. Older children experience headaches, nausea, balance problems, and cognitive difficulties. Hydrocephalus often requires surgical placement of a shunt—a thin tube that drains excess fluid to another part of the body where it can be absorbed.[14]

Seizures represent another potential complication when the tumor irritates brain tissue. These can range from brief episodes of staring or unusual sensations to full-body convulsions. Seizures occur because the tumor disrupts normal electrical signaling in the brain. Even after treatment begins, some children continue experiencing seizures and may require anti-seizure medications for extended periods.[15]

Neurological deficits can develop based on tumor location. Children may experience weakness or paralysis on one side of the body, difficulty speaking or understanding language, vision problems, or coordination issues. When tumors affect the spinal cord, complications can include loss of sensation below the tumor level, difficulty walking, and problems controlling bladder and bowel function. Some of these deficits may improve with treatment, while others might persist long-term.[14]

Hormonal imbalances can occur if the tumor affects areas of the brain that regulate hormone production, such as the hypothalamus or pituitary gland. This might result in problems with growth, puberty, thyroid function, or fluid balance in the body. These complications often require ongoing monitoring and hormone replacement therapies.

Treatment itself can introduce complications. Surgery carries risks of bleeding, infection, and damage to surrounding healthy brain tissue. Chemotherapy—the use of powerful drugs to kill cancer cells—can cause nausea, hair loss, increased infection risk due to lowered immune function, and fatigue. Radiation therapy may affect developing brain tissue, potentially impacting cognitive development, learning, and memory. These treatment-related complications must be weighed against the necessity of controlling the cancer.[14]

⚠️ Important
Recognizing early warning signs of complications can be life-saving. Contact your medical team immediately if your child develops severe headaches, persistent vomiting, vision changes, seizures, sudden weakness, loss of consciousness, or fever during chemotherapy. Many complications are manageable when caught early, but delays in treatment can lead to permanent damage.

Impact on Daily Life and Family Functioning

A diagnosis of central nervous system neuroblastoma profoundly affects every aspect of a child’s and family’s daily existence. The disease and its treatment create challenges that extend far beyond medical appointments, touching emotional wellbeing, family relationships, school participation, and practical matters of daily living.

Physically, children often experience significant limitations. Depending on tumor location and treatment stage, they may face chronic fatigue that makes even simple activities exhausting. A child who once ran and played freely might now need frequent rest periods. Treatments like chemotherapy can cause nausea, making mealtimes difficult and leading to weight loss or nutritional concerns. Some children develop weakness or coordination problems that affect their ability to dress themselves, write, or participate in physical activities they previously enjoyed.[20]

The emotional and psychological impact on the child is substantial. Young children may not fully understand why they feel sick or why they must undergo uncomfortable procedures. They may experience fear around medical settings, anxiety about separation from parents, or frustration at being unable to do what other children do. Older children and adolescents often struggle with feeling different from peers, dealing with changes in appearance (such as hair loss from chemotherapy), and processing the reality of having a serious illness. Many children benefit from age-appropriate counseling to help them cope with these emotional challenges.[20]

School attendance typically becomes irregular, with frequent absences for treatment, recovery periods, and medical appointments. This disruption affects not only academic progress but also social connections with classmates and teachers. Some children require special educational services, including tutoring, modified assignments, or accommodations for cognitive changes that may result from the tumor or treatment. Maintaining some connection to school and peers, when possible, helps preserve a sense of normalcy and social belonging.

For parents and caregivers, the disease creates enormous stress and practical challenges. One or both parents often need to reduce work hours or stop working entirely to provide care and attend countless medical appointments. The financial strain can be severe, with medical bills, travel costs for treatment, and lost income combining to create significant hardship. Insurance coverage, even when present, may not cover all expenses, and families may face difficult decisions about treatment options based partly on cost.

Siblings of the sick child experience their own challenges. They may feel neglected as parents’ attention necessarily focuses on the ill child. They might feel guilty for being healthy, angry at the disruption to family life, or frightened about their sibling’s condition and future. Siblings need age-appropriate information, reassurance, and dedicated attention from parents or other caring adults. Family counseling can help all family members process their feelings and maintain healthy relationships during this stressful period.[20]

Daily routines become organized around treatment schedules, medication timing, dietary restrictions, and symptom management. Parents become expert caregivers, learning to manage feeding tubes, recognize signs of complications, administer medications correctly, and monitor their child’s condition. This responsibility is physically exhausting and emotionally draining, leaving little time for self-care or attention to other family needs.

Sleep disruption affects the entire household. The sick child may have difficulty sleeping due to pain, discomfort, anxiety, or medication side effects. Parents often wake frequently to check on their child or respond to nighttime needs. Chronic sleep deprivation impacts everyone’s mood, patience, and ability to cope with daily challenges.

Social isolation often develops as families withdraw from normal activities. Other children may not be able to visit if the patient is immunocompromised from chemotherapy. Family outings may be impossible during treatment periods. Parents may have little energy for maintaining friendships or social connections. This isolation can deepen feelings of loneliness and depression for all family members.

Despite these challenges, many families find unexpected sources of strength. Some discover deeper connections within the family, develop resilience they didn’t know they possessed, and form meaningful relationships with other families facing similar challenges. Practical coping strategies that help families include: establishing routines where possible to provide structure and predictability; accepting help from extended family, friends, or community organizations; taking breaks when opportunities arise to prevent complete burnout; focusing on small achievable goals rather than feeling overwhelmed by the entire situation; and finding ways to celebrate small victories and maintain hope.[20]

Supporting Families Through Clinical Trial Participation

Clinical trials represent important opportunities for advancing knowledge about central nervous system neuroblastoma and potentially accessing new treatments not yet widely available. However, families facing this diagnosis often feel overwhelmed and may not fully understand what clinical trials are, how they work, or whether participation might benefit their child.

A clinical trial is a carefully controlled research study that tests whether new treatments, diagnostic techniques, or preventive strategies are safe and effective. For rare cancers like central nervous system neuroblastoma, clinical trials are particularly important because the small number of cases makes it difficult to develop evidence-based treatment guidelines through traditional means. Each child who participates contributes valuable information that may help future children facing the same diagnosis.[2]

Families should understand that clinical trials have strict protocols designed to protect participants. Before any trial begins, it must be reviewed and approved by ethics committees called Institutional Review Boards that ensure the study design is scientifically sound and that patient safety is prioritized. Participation is always voluntary, and families can withdraw at any time without affecting their child’s access to standard care. Researchers must provide detailed information about the study’s purpose, procedures, potential risks and benefits, and alternatives to participation through a process called informed consent.

Different types of clinical trials serve different purposes. Some test entirely new treatments that have shown promise in laboratory studies but haven’t yet been used in humans. Others compare new approaches to current standard treatments to see if the new method works better. Still others study ways to reduce treatment side effects or improve quality of life during treatment. Understanding which type of trial is being considered helps families make informed decisions.

Finding appropriate clinical trials for central nervous system neuroblastoma requires research and often assistance from the medical team. Not all trials are suitable for every patient—eligibility criteria consider factors like age, tumor characteristics, previous treatments received, and overall health status. Oncologists and research coordinators can search trial databases and identify studies that might be appropriate options. Families can also search independently through registries, though interpretation of medical eligibility criteria can be challenging without professional guidance.[2]

Relatives and family members play crucial roles in supporting clinical trial participation. They can help research available trials, accompany the patient to appointments, ask questions the parents might not think of, provide emotional support during difficult treatment phases, and help with practical matters like transportation and childcare for siblings. Extended family members can also assist with understanding complex medical information, taking notes during doctor visits, and helping parents process decisions when stress makes clear thinking difficult.

Practical considerations for trial participation include potential additional appointments, more frequent monitoring, travel to specialized centers offering the trial, and time commitments beyond standard treatment. Some trials cover certain costs, while others may not. Families should ask detailed questions about logistical requirements and financial implications before committing. Social workers and patient navigators at treatment centers can often help families address practical barriers to participation.

The emotional aspects of considering trial participation can be complex. Some families feel hopeful about accessing potentially better treatments. Others worry about unknown risks or feel uncertain about whether they’re making the right choice. It’s normal to experience conflicting feelings. Families benefit from thorough discussions with the medical team, time to consider all information without pressure, and possibly seeking second opinions. Connecting with other families who have participated in trials can provide valuable perspectives, though every situation is unique.

Throughout the process, families should feel empowered to ask questions repeatedly until they fully understand. Questions should cover what the trial aims to learn, how treatment in the trial differs from standard treatment, what additional tests or procedures are required, what risks and side effects are possible, what happens if the treatment doesn’t work, who will be responsible for care, and what costs the family will incur. There are no foolish questions when making decisions about a child’s treatment.

If participating in a trial, maintaining open communication with the research team is essential. Parents should report any symptoms, side effects, or concerns promptly. Keeping detailed records of appointments, treatments received, and any changes in the child’s condition helps ensure accurate reporting and may provide valuable information for the study. This documentation also creates a comprehensive medical history that could be useful for future care decisions.

Ongoing Clinical Trials on Central nervous system neuroblastoma

  • Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

    Recruiting

    1 1 1 1
    Austria France Germany Italy The Netherlands Poland +1

References

https://www.mayoclinic.org/diseases-conditions/neuroblastoma/symptoms-causes/syc-20351017

https://www.yalemedicine.org/clinical-keywords/central-nervous-system-neuroblastoma

https://my.clevelandclinic.org/health/diseases/14390-neuroblastoma

https://cancer.ca/en/cancer-information/cancer-types/neuroblastoma/what-is-neuroblastoma

https://www.ncbi.nlm.nih.gov/books/NBK448111/

https://www.chop.edu/conditions-diseases/neuroblastoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC5419586/

https://www.cancer.gov/types/brain/patient/child-cns-embryonal-treatment-pdq

https://medlineplus.gov/ency/article/001408.htm

https://www.mskcc.org/pediatrics/cancer-care/types/neuroblastoma

https://www.ncbi.nlm.nih.gov/books/NBK65747/

https://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq

https://my.clevelandclinic.org/health/diseases/14390-neuroblastoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC9662237/

https://surgicalneurologyint.com/surgicalint-articles/pediatric-central-nervous-system-cns-neuroblastoma-a-case-report/

https://www.yalemedicine.org/clinical-keywords/central-nervous-system-neuroblastoma

https://www.chop.edu/conditions-diseases/neuroblastoma

https://my.clevelandclinic.org/health/diseases/14390-neuroblastoma

https://www.yalemedicine.org/conditions/neuroblastoma

https://careoptionsforkids.com/blog/caring-for-a-child-with-neuroblastoma/

https://www.stanfordchildrens.org/en/topic/default?id=neuroblastoma-90-P02735/

https://www.cancer.org/cancer/types/neuroblastoma/after-treatment.html

https://www.ummhealth.org/health-library/neuroblastoma

https://www.mskcc.org/pediatrics/cancer-care/types/neuroblastoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC7158874/

https://www.nationwidechildrens.org/conditions/health-library/neuroblastoma

https://www.healthline.com/health/neuroblastoma

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What is the difference between regular neuroblastoma and central nervous system neuroblastoma?

Regular neuroblastoma typically develops outside the central nervous system, most commonly in the adrenal glands near the kidneys or along nerve tissue in the abdomen, chest, or pelvis. Central nervous system neuroblastoma specifically originates within the brain or spinal cord. While both arise from similar immature nerve cells, their location makes CNS neuroblastoma rarer and creates different treatment challenges since tumors in the brain or spinal cord are more difficult to access surgically without affecting critical functions.

How is central nervous system neuroblastoma diagnosed in children?

Diagnosis typically begins when symptoms prompt imaging studies. Magnetic resonance imaging (MRI) scans are the primary tool for visualizing tumors in the brain and spinal cord. If imaging suggests neuroblastoma, doctors usually perform a biopsy—removing a small tissue sample during surgery—to examine cells under a microscope and confirm the diagnosis. Additional tests may include analysis of cerebrospinal fluid, genetic testing of tumor tissue to identify specific mutations, and scans to check whether cancer has spread to other body areas.

Can central nervous system neuroblastoma be cured?

The possibility of cure depends on multiple factors including the tumor’s location, whether it can be completely removed surgically, the child’s age, and specific genetic characteristics of the cancer cells. Some children achieve long-term survival with no evidence of disease after treatment, which may include surgery, chemotherapy, and radiation therapy. However, because this cancer is so rare, definitive cure rates are difficult to establish. Each case is unique, and prognosis discussions should happen directly with your child’s oncology team based on specific circumstances.

What are the main treatment options for this condition?

Treatment typically involves multiple approaches. Surgery to remove as much tumor as possible is usually attempted when safe to do so. Chemotherapy uses powerful medications to kill cancer cells throughout the body. Radiation therapy directs high-energy beams at the tumor site to destroy remaining cancer cells. The specific combination and sequence of treatments depend on tumor characteristics, location, and whether cancer has spread. Some children may also be candidates for clinical trials testing new approaches.

Will my child need long-term follow-up care after treatment?

Yes, long-term follow-up is essential for children treated for central nervous system neuroblastoma. Regular monitoring includes imaging scans to check for cancer recurrence, assessments of neurological function and development, monitoring for late effects of treatment on growth and cognitive abilities, and management of any ongoing complications. The frequency of follow-up visits typically decreases over time if no problems develop, but some level of monitoring usually continues for many years after treatment ends.

🎯 Key Takeaways

  • Central nervous system neuroblastoma is an extremely rare childhood cancer that develops directly in the brain or spinal cord, unlike typical neuroblastomas that form elsewhere in the body.
  • The tumor originates from immature nerve cells that failed to develop properly during fetal development, representing embryonic cells that continue growing abnormally after birth.
  • Prognosis varies significantly based on tumor location, age at diagnosis, whether complete surgical removal is possible, and specific genetic characteristics of the cancer cells.
  • Without treatment, the tumor continues growing and pressing on brain tissue, potentially causing life-threatening complications including increased intracranial pressure and neurological damage.
  • Complications can arise from both the tumor itself and from treatments, including neurological deficits, seizures, hormonal imbalances, and cognitive changes affecting learning and development.
  • The disease profoundly impacts daily life for the entire family, affecting the child’s physical abilities, emotional wellbeing, school participation, and creating significant stress for parents and siblings.
  • Clinical trials offer opportunities to access new treatments and contribute to research, though families should carefully consider eligibility criteria, potential benefits and risks, and practical implications before participating.
  • Family members play crucial roles in supporting both the patient and parents through researching treatment options, providing emotional support, helping with practical needs, and maintaining communication with medical teams.